Chronic Kidney Disease Treatment in Navi Mumbai

Chronic Kidney Disease

Chronic Kidney Disease (CKD) is a condition that progresses quietly over months and years, causing no obvious discomfort until kidney function has already declined substantially. By the time swelling appears around the ankles or eyes, or fatigue becomes difficult to ignore, the kidneys may be functioning at less than half their normal capacity. That is the central problem with CKD. And it is exactly why we emphasize early screening for anyone with known risk factors.

Each kidney contains approximately one million filtering units called nephrons, concentrated largely in the outer cortex of the organ. In CKD, these nephrons are progressively damaged and lost, reducing the kidneys' ability to filter waste products, regulate fluid and electrolyte balance, and produce hormones like erythropoietin that stimulate red blood cell production. The damage, once established, is largely irreversible. What treatment does is slow the rate of further loss, not restore what is already gone. This is why early intervention matters more than most patients initially appreciate.

In our experience, two conditions account for the majority of CKD cases we manage:

  • Diabetes, both type 1 and type 2
  • Uncontrolled hypertension
  • Glomerulonephritis, an inflammatory condition
  • Polycystic kidney disease, an inherited condition
  • Recurrent urinary tract infections
  • Autoimmune conditions

CKD is classified into five stages based on eGFR, the estimated glomerular filtration rate, which reflects how much filtering capacity the kidneys still retain.

  • Stage 1 (eGFR 90 or above)
    Kidney structure may be abnormal, but function is largely preserved. Most patients have no symptoms. Detected incidentally through urine protein or imaging findings
  • Stage 2 (eGFR 60 to 89)
    Mildly reduced function. Still largely asymptomatic. Risk factor control at this stage can significantly slow progression
  • Stage 3a (eGFR 45 to 59) and Stage 3b (eGFR 30 to 44)
    Moderately reduced function. This is where early complications such as anaemia, mild bone changes, and blood pressure instability begin to appear. Most patients receive their first CKD diagnosis at this stage
  • Stage 4 (eGFR 15 to 29)
    Severely reduced function. Symptoms are often more pronounced at this point. Active preparation for renal replacement therapy, either dialysis or transplant evaluation, begins here
  • Stage 5 (eGFR below 15)
    End-stage renal disease. The kidneys can no longer sustain essential body functions independently. Dialysis or a kidney transplant becomes necessary to maintain life

The earlier CKD is identified on this scale, the more options are available to slow its progression and delay the need for renal replacement therapy.

  • Persistent puffiness around the eyes, particularly noticeable in the morning
  • Swelling of the ankles and feet that does not resolve with rest
  • Foamy or frothy urine, which may indicate protein leakage through damaged glomeruli
  • Unexplained fatigue and weakness that disrupts daily routine
  • Frequent urination at night, more than once or twice
  • Blood pressure that is increasingly difficult to control despite medication
  • Mild but persistent nausea without an obvious cause

  • Serum creatinine and eGFR are the primary markers of kidney filtration capacity
  • Urine albumin to creatinine ratio detects early protein leakage before creatinine rises significantly
  • Complete blood count identifies anaemia from reduced erythropoietin production
  • Electrolyte panel monitors potassium, bicarbonate, and phosphate levels
  • Parathyroid hormone is tracked because CKD disrupts calcium and phosphate balance, leading to bone disease
  • Renal ultrasound assesses kidney size, cortical thickness, and structural abnormalities
  • Kidney biopsy is performed selectively when the underlying cause is unclear or when an inflammatory or autoimmune process is suspected

As kidney function declines, three complications emerge consistently. Anaemia develops from reduced erythropoietin production, causing fatigue and breathlessness. Bone disease follows from impaired vitamin D activation, leading to fractures and bone pain. Cardiovascular risk rises significantly due to fluid retention, hypertension, and chronic inflammation, often becoming the primary cause of mortality.

This is where consistent clinical management makes a measurable difference.

  • Strict blood pressure control
  • Blood glucose management in diabetic patients
  • SGLT2 inhibitors, a class of diabetes medication when needed
  • Avoiding nephrotoxic medications as much as possible
  • Staying well hydrated and treating urinary infections promptly

The best chronic kidney disease doctors in Navi Mumbai at UMC Hospitals help manage this condition.

Dietary management in CKD is nuanced and changes with each stage.

In earlier stages, a moderately low protein diet reduces the filtration load on remaining nephrons. Potassium restriction becomes necessary when serum potassium rises above 5.5 mEq/L. Phosphate restriction, limiting dairy, nuts, and processed foods, is important from stage 3 onward. Sodium restriction helps manage blood pressure and fluid retention. Fluid intake may need to be limited in advanced stages, particularly once urine output begins to decline.

If your creatinine has been reported as elevated even once, do not wait for it to rise further before seeking specialist input. Patients with diabetes or hypertension should have their kidney function tested at least annually. Anyone with a family history of kidney disease, persistent protein in the urine, or blood pressure that requires multiple medications to control should be evaluated by a nephrologist sooner rather than later.

Our nephrology team at UMC Hospitals provides the best chronic kidney disease treatment in Navi Mumbai and manages CKD across all five stages with a structured, investigation-guided approach. From early-stage lifestyle and medication management to dialysis initiation and transplant evaluation, care is coordinated under one team rather than fragmented across departments. Monthly monitoring, dietary support, and cardiovascular risk management are built into every CKD care plan. Our goal is to preserve kidney function for as long as clinically possible and to prepare patients thoroughly for the next stage of treatment when that time comes.